Description: enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based devices to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and works as a replacement venous valve to reduce reflux and venous hypertension, as well as to restore proper directional blood flow back to the heart. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Home Page: www.envveno.com
70 Doppler
Irvine,
CA
92618
United States
Phone:
949 261 2900
Officers
| Name | Title |
|---|---|
| Mr. Robert A. Berman | CEO & Director |
| Mr. Craig Thomas Glynn | CFO, Treasurer & Sec. |
| Dr. Marc H. Glickman M.D. | Sr. VP & Chief Medical Officer |
| Mr. Warren Hancock | Co-founder |
| Dr. Benedict Broennimann M.D. | Chief Medical Officer of Outside of United States |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 19 |